Covid-19 - Kanta Medicos

The novel coronavirus was first detected in Wuhan City, Hubei province, China in December 2019 and since then rapidly spread across the world. On 11 March, the World Health Organization (WHO) declared COVID-19 a pandemic..

As a global organization representing the cardiovascular community, Kanta Medicos is committed to offering the latest evidence of the outbreak and ensuring everyone is aware of the necessary measures to protect themselves and others in order to slow the spread of the disease.

The Kanta Medicos Global Study on CVD and COVID-19 aims to investigate the intersection between cardiovascular diseases (CVD) and COVID-19. This study explores how COVID-19 impacts individuals with pre-existing cardiovascular conditions, identifies risk factors, and assesses management strategies to improve patient outcomes.

SIGNS & SYMPTOMS

Symptoms of the infection may appear 2-14 days after exposure and include:

Sore throat
Cough
Fever

If you develop emergency warning signs, get medical attention immediately. Warning signs may include:

Difficulty breathing or shortness of breath
Persistent pain or pressure in the chest
New confusion or inability to arouse
Bluish lips or face

Research suggests that some individuals are more vulnerable to the worst outcomes of the virus:

Older adults
People who have serious chronic medical conditions like diabetes or heart disease

Subscribe To Our Newsletter

The Major activity of Kanta Medicos is WholeSale and Export, Sub-classified into human health activities and provides thousands of prescription medications on both brand name and generic labels.

Quick Links

[wcmc_currency_selector]

Our Services

Help Us

Contact Info

The Major activity of Kanta Medicos is WholeSale and Export, Sub-classified into human health activities and provides thousands of prescription medications on both brand name and generic labels.